亲密伴侣暴力:基层医疗当前筛查实践分析
该研究回顾性分析美国东南佛罗里达州四家大学附属基层诊所400例年度体检患者,发现亲密伴侣暴力(IPV)筛查率仅8.5%,远低于焦虑(37.3%)和抑郁(71.3%)筛查;已记录的IPV筛查中64.7%遭患者拒绝。作者认为低筛查率和低筛查成功率对推行普遍IPV筛查提出质疑,需进一步研究筛查完成障碍。
要点
- IPV筛查率8.5%,远低于焦虑筛查37.3%和抑郁筛查71.3%。
- 已记录的IPV筛查中64.7%的患者拒绝回答相关问题。
- 筛查率受患者族裔影响边缘显著(P=0.052)。
核心结论
- IPV筛查率低且筛查成功率低,对倡导普遍IPV筛查提出质疑,需进一步识别筛查完成的隐藏障碍。
研究设计与样本
- 回顾性研究,纳入美国东南佛罗里达州四家大学附属基层诊所年度体检患者400例,从病历收集人口学、筛查完成及结果数据。
主要发现
- IPV筛查率8.5%,低于焦虑筛查37.3%和抑郁筛查71.3%。
- 已记录的IPV筛查中64.7%的 encounters 患者拒绝接受筛查。
- 筛查率受患者族裔影响边缘显著(P=0.052)。
关键数值与推荐
- IPV筛查率8.5%,焦虑筛查率37.3%,抑郁筛查率71.3%。
- 已记录IPV筛查中患者拒绝率64.7%。
- 族裔对筛查率影响P=0.052。
临床怎么用
- 基层医生应关注IPV筛查率远低于焦虑和抑郁筛查的现状,并注意患者拒绝筛查比例较高的问题。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intimate partner violence (IPV) is a largely undetected occurrence in the United States reported by 36-50% of women in their lifetime and associated with extensive physical and psychological implications. Currently, conflicting recommendations exist regarding screening practices with the United States Preventative Services Task Force (USPSTF) and the World Health Organization (WHO) advocating for and against universal screening, respectively. With research suggesting that women are seldom asked about IPV during clinic visits, further information is needed regarding current screening practices. OBJECTIVES: To identify current IPV screening approaches in the primary care setting and factors that may impact screening completion. METHODS: We retrospectively examined patients presenting for annual examinations at four university-associated primary care clinics in southeast Florida (n = 400). Patient demographics, screener demographics, screening completion, and screening results were collected from the medical record. Results were compared to depression and anxiety screenings due to comparable prevalence and screening recommendations. Pearson chi square and Fisher exact tests were utilized to compare screening rates by demographic characteristics. RESULTS: IPV screening occurred at a much lower frequency (8.5%) compared to screenings for anxiety (37.3%) and depression (71.3%). Among documented IPV screenings, 64.7% of encounters resulted in patient refusal to be screened. Screening rates were found to be marginally impacted by patient ethnicity (P = 0.052). CONCLUSIONS: Findings of both low screening rates and low screening success raise significant concerns for the shortcomings of advocating for universal IPV screening. Therefore, additional studies are necessary to identify covert barriers to screening completion before universal inquiry is advised. Intimate partner violence (IPV) is a largely undetected occurrence reported by 36–50% of women in their lifetime. Currently, IPV screening recommendations vary across organizations like the USPSTF and WHO. Given its widespread impact, we aimed to identify current IPV screening practices and gaps using patients who presented for annual examinations at four primary care clinics (n = 400). Patient demographics, screener demographics, screening completion, and screening results were collected from the medical record. IPV screening frequency was compared to frequency of depression and anxiety screenings given comparable screening recommendations and prevalence. IPV screening occurred less frequently (8.5%) compared to anxiety (37.3%) and depression (71.3%) screenings. Out of attempted IPV screens, 64.7% resulted in patient refusal to answer related questions. IPV screening rates were marginally impacted by patient ethnicity (P = 0.052). Our findings suggest shortcomings of universal screening and highlight the necessity to further elucidate barriers and improve screening efficacy.
引用
- Perone HR, Dietz NA, Belkowitz J, et al. Intimate partner violence: analysis of current screening practices in the primary care setting. Fam Pract. 2022. PMID: 34184740. doi:10.1093/fampra/cmab069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。